CST30 was isolated from a BRAF-mutant tumor and is characterized by a neural crest-like/transitory differentiation program, as shown by higher expression of genes as MITF, SOX10, PMEL, MLANA, TYR, DCT, ERBB3 (Suppl. Here, DCT is linked to neoplasm.